vs
Side-by-side financial comparison of AMERISAFE INC (AMSF) and Lifevantage Corp (LFVN). Click either name above to swap in a different company.
AMERISAFE INC is the larger business by last-quarter revenue ($80.1M vs $48.9M, roughly 1.6× Lifevantage Corp). AMERISAFE INC runs the higher net margin — 10.2% vs 0.6%, a 9.6% gap on every dollar of revenue. On growth, AMERISAFE INC posted the faster year-over-year revenue change (10.3% vs -27.8%). Over the past eight quarters, AMERISAFE INC's revenue compounded faster (2.8% CAGR vs 0.7%).
AMERISAFE Inc. is a specialty insurance provider that focuses exclusively on workers' compensation coverage for small and mid-sized businesses in high-hazard industries including construction, logging, trucking, and manufacturing. It operates across 49 U.S. states, offering tailored insurance policies paired with targeted risk management support for clients.
Lifevantage Corp is a health and wellness enterprise that develops, manufactures and distributes science-backed nutritional supplements, skincare and personal care products. It operates via a direct-to-consumer network marketing model, serving customers across North America, Europe and the Asia-Pacific, with focus on anti-aging and holistic health solution segments.
AMSF vs LFVN — Head-to-Head
Income Statement — Q1 FY2026 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $80.1M | $48.9M |
| Net Profit | $8.1M | $276.0K |
| Gross Margin | — | 74.0% |
| Operating Margin | — | 1.0% |
| Net Margin | 10.2% | 0.6% |
| Revenue YoY | 10.3% | -27.8% |
| Net Profit YoY | -9.0% | -89.2% |
| EPS (diluted) | $0.43 | $0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $80.1M | — | ||
| Q4 25 | $81.6M | $48.9M | ||
| Q3 25 | $82.0M | $47.6M | ||
| Q2 25 | $81.1M | $55.1M | ||
| Q1 25 | $72.6M | $58.4M | ||
| Q4 24 | $74.0M | $67.8M | ||
| Q3 24 | $78.7M | $47.2M | ||
| Q2 24 | $75.8M | $48.9M |
| Q1 26 | $8.1M | — | ||
| Q4 25 | $10.4M | $276.0K | ||
| Q3 25 | $13.8M | $2.2M | ||
| Q2 25 | $14.0M | $2.0M | ||
| Q1 25 | $8.9M | $3.5M | ||
| Q4 24 | $13.2M | $2.5M | ||
| Q3 24 | $14.3M | $1.8M | ||
| Q2 24 | $11.0M | $1.3M |
| Q1 26 | — | — | ||
| Q4 25 | — | 74.0% | ||
| Q3 25 | — | 79.5% | ||
| Q2 25 | — | 79.9% | ||
| Q1 25 | — | 81.0% | ||
| Q4 24 | — | 80.5% | ||
| Q3 24 | — | 79.9% | ||
| Q2 24 | — | 79.5% |
| Q1 26 | — | — | ||
| Q4 25 | 15.6% | 1.0% | ||
| Q3 25 | 21.3% | 4.8% | ||
| Q2 25 | 21.5% | 3.9% | ||
| Q1 25 | 15.5% | 6.9% | ||
| Q4 24 | 22.7% | 5.1% | ||
| Q3 24 | 22.6% | 5.4% | ||
| Q2 24 | 18.1% | 5.9% |
| Q1 26 | 10.2% | — | ||
| Q4 25 | 12.8% | 0.6% | ||
| Q3 25 | 16.9% | 4.5% | ||
| Q2 25 | 17.2% | 3.6% | ||
| Q1 25 | 12.3% | 5.9% | ||
| Q4 24 | 17.8% | 3.8% | ||
| Q3 24 | 18.2% | 3.9% | ||
| Q2 24 | 14.5% | 2.7% |
| Q1 26 | $0.43 | — | ||
| Q4 25 | $0.55 | $0.02 | ||
| Q3 25 | $0.72 | $0.17 | ||
| Q2 25 | $0.73 | $0.16 | ||
| Q1 25 | $0.47 | $0.26 | ||
| Q4 24 | $0.69 | $0.19 | ||
| Q3 24 | $0.75 | $0.14 | ||
| Q2 24 | $0.57 | $0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $34.2M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $246.6M | $33.0M |
| Total Assets | — | $61.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $34.2M | — | ||
| Q4 25 | $61.9M | — | ||
| Q3 25 | $54.7M | — | ||
| Q2 25 | $48.5M | $20.2M | ||
| Q1 25 | $44.8M | — | ||
| Q4 24 | $44.1M | — | ||
| Q3 24 | $63.7M | — | ||
| Q2 24 | $30.6M | $16.9M |
| Q1 26 | $246.6M | — | ||
| Q4 25 | $251.6M | $33.0M | ||
| Q3 25 | $274.8M | $33.2M | ||
| Q2 25 | $265.6M | $34.6M | ||
| Q1 25 | $260.8M | $34.0M | ||
| Q4 24 | $257.3M | $29.9M | ||
| Q3 24 | $314.4M | $27.7M | ||
| Q2 24 | $301.0M | $26.0M |
| Q1 26 | — | — | ||
| Q4 25 | $1.1B | $61.2M | ||
| Q3 25 | $1.2B | $61.6M | ||
| Q2 25 | $1.2B | $72.0M | ||
| Q1 25 | $1.2B | $77.2M | ||
| Q4 24 | $1.2B | $68.5M | ||
| Q3 24 | $1.3B | $61.5M | ||
| Q2 24 | $1.2B | $60.3M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $2.8M |
| Free Cash FlowOCF − Capex | — | $1.7M |
| FCF MarginFCF / Revenue | — | 3.5% |
| Capex IntensityCapex / Revenue | — | 2.2% |
| Cash ConversionOCF / Net Profit | — | 10.11× |
| TTM Free Cash FlowTrailing 4 quarters | — | $1.7M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $11.1M | $2.8M | ||
| Q3 25 | $10.7M | $-2.3M | ||
| Q2 25 | $-8.4M | $1.0M | ||
| Q1 25 | $-1.8M | $2.2M | ||
| Q4 24 | $24.2M | $9.2M | ||
| Q3 24 | $8.4M | $-583.0K | ||
| Q2 24 | $-2.6M | $2.6M |
| Q1 26 | — | — | ||
| Q4 25 | $8.9M | $1.7M | ||
| Q3 25 | $9.8M | $-2.7M | ||
| Q2 25 | $-9.5M | $835.0K | ||
| Q1 25 | $-1.8M | $1.9M | ||
| Q4 24 | $23.4M | $8.7M | ||
| Q3 24 | $8.4M | $-932.0K | ||
| Q2 24 | $-2.6M | $2.3M |
| Q1 26 | — | — | ||
| Q4 25 | 10.9% | 3.5% | ||
| Q3 25 | 11.9% | -5.8% | ||
| Q2 25 | -11.7% | 1.5% | ||
| Q1 25 | -2.5% | 3.2% | ||
| Q4 24 | 31.5% | 12.8% | ||
| Q3 24 | 10.7% | -2.0% | ||
| Q2 24 | -3.5% | 4.7% |
| Q1 26 | — | — | ||
| Q4 25 | 2.6% | 2.2% | ||
| Q3 25 | 1.1% | 0.9% | ||
| Q2 25 | 1.3% | 0.4% | ||
| Q1 25 | 0.0% | 0.6% | ||
| Q4 24 | 1.1% | 0.7% | ||
| Q3 24 | 0.0% | 0.7% | ||
| Q2 24 | 0.1% | 0.6% |
| Q1 26 | — | — | ||
| Q4 25 | 1.06× | 10.11× | ||
| Q3 25 | 0.77× | -1.07× | ||
| Q2 25 | -0.61× | 0.53× | ||
| Q1 25 | -0.20× | 0.64× | ||
| Q4 24 | 1.83× | 3.61× | ||
| Q3 24 | 0.59× | -0.32× | ||
| Q2 24 | -0.24× | 1.98× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
